Now liveThe Skillselion MCP - thousands of ranked skills, loaded into your agent mid-task. No install.Get it →
mims-harvard avatar

Tooluniverse Multiomic Disease Characterization

  • 315 installs
  • 1.6k repo stars
  • Updated August 4, 2026
  • mims-harvard/tooluniverse

tooluniverse-multiomic-disease-characterization is a biomedical agent skill that integrates genomics, transcriptomics, proteomics, and pathway data across nine phases for developers producing systems-level disease mechan

About

tooluniverse-multiomic-disease-characterization is a mims-harvard/ToolUniverse skill for full-omics disease deep dives. After disease disambiguation to MONDO/EFO identifiers, it runs nine phases covering GWAS genetics, GTEx expression across 54 tissues, STRING PPI networks, Reactome and Enrichr pathway enrichment, GO annotation, therapeutic landscape via DGIdb and clinical trials, cross-layer integration, and a 0–100 Multi-Omics Confidence Score with T1–T4 evidence grading. The report-first workflow creates a markdown report before populating sections progressively. Reference files include tool-reference.md, report-template.md, integration-scoring.md, response-formats.md, and use-patterns.md. Use when agents must connect variants to expression, protein interactions, pathways, druggable targets, and biomarker hypotheses in one structured translational report.

  • Cross-omic disease integration tools
  • Biomarker and subtype hypothesis support
  • Layered evidence aggregation
  • ToolUniverse multi-omic connectors
  • Translational research agent workflows

Tooluniverse Multiomic Disease Characterization by the numbers

  • 315 all-time installs (skills.sh)
  • +5 installs in the week ending Aug 4, 2026 (Skillselion tracking)
  • Ranked #575 of 2,064 Data Science & ML skills by installs in the Skillselion catalog
  • Data as of Aug 5, 2026 (Skillselion catalog sync)
npx skills add https://github.com/mims-harvard/tooluniverse --skill tooluniverse-multiomic-disease-characterization

Add your badge

Show developers this skill is listed on Skillselion. Paste this into your README.

Listed on Skillselion
Installs315
repo stars1.6k
Last updatedAugust 4, 2026
Repositorymims-harvard/tooluniverse

How do you characterize disease mechanisms across omics layers?

Help agents integrate genomics, transcriptomics, proteomics, and metabolomics signals to characterize disease mechanisms, biomarkers, and subtype hypotheses in translational projects.

Who is it for?

Translational bioinformatics engineers building agents that synthesize genomics, transcriptomics, proteomics, and pathway evidence into unified disease characterization reports.

Skip if: Single-gene drug-target validation only, adverse-event safety profiling, or quick disease summaries without cross-omics integration and scored evidence grading.

When should I use this skill?

User needs multi-omics disease characterization, cross-layer mechanism mapping, biomarker discovery, or druggable target identification from integrated molecular data

What you get

Multi-omics markdown reports, cross-layer gene concordance tables, biomarker candidates, druggable targets, and confidence scores

  • multi-omics disease reports
  • biomarker candidate lists
  • druggable target rankings

By the numbers

  • Runs a 9-phase multi-omics characterization pipeline
  • GTEx expression summary covers 54 tissues
  • Multi-Omics Confidence Score ranges 0–100 with T1–T4 evidence grades

Files

SKILL.mdMarkdownGitHub ↗

Multi-Omics Disease Characterization Pipeline

Characterize diseases across multiple molecular layers (genomics, transcriptomics, proteomics, pathways) to provide systems-level understanding of disease mechanisms, identify therapeutic opportunities, and discover biomarker candidates.

KEY PRINCIPLES: 1. Report-first approach - Create report file FIRST, then populate progressively 2. Disease disambiguation FIRST - Resolve all identifiers before omics analysis 3. Layer-by-layer analysis - Systematically cover all omics layers 4. Cross-layer integration - Identify genes/targets appearing in multiple layers 5. Evidence grading - Grade all evidence as T1 (human/clinical) to T4 (computational) 6. Tissue context - Emphasize disease-relevant tissues/organs 7. Quantitative scoring - Multi-Omics Confidence Score (0-100) 8. Druggable focus - Prioritize targets with therapeutic potential 9. Biomarker identification - Highlight diagnostic/prognostic markers 10. Mechanistic synthesis - Generate testable hypotheses 11. Source references - Every statement must cite tool/database 12. Completeness checklist - Mandatory section showing analysis coverage 13. English-first queries - Always use English terms in tool calls. Respond in user's language

Multi-omics disease characterization asks: what molecular layers are dysregulated? Genomic mutations → transcriptomic changes → proteomic effects → metabolomic consequences. Concordance across layers strengthens the finding. Discordance reveals regulatory complexity.

LOOK UP, DON'T GUESS

When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory. A database-verified answer is always more reliable than a guess.

---

COMPUTE, DON'T DESCRIBE

When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.

When to Use This Skill

Apply when users:

  • Ask about disease mechanisms across omics layers
  • Need multi-omics characterization of a disease
  • Want to understand disease at the systems biology level
  • Ask "What pathways/genes/proteins are involved in [disease]?"
  • Need biomarker discovery for a disease
  • Want to identify druggable targets from disease profiling
  • Ask for integrated genomics + transcriptomics + proteomics analysis
  • Need cross-layer concordance analysis
  • Ask about disease network biology / hub genes

NOT for (use other skills instead):

  • Single gene/target validation -> Use tooluniverse-drug-target-validation
  • Drug safety profiling -> Use tooluniverse-adverse-event-detection
  • General disease overview -> Use tooluniverse-disease-research
  • Variant interpretation -> Use tooluniverse-variant-interpretation
  • GWAS-specific analysis -> Use tooluniverse-gwas-* skills
  • Pathway-only analysis -> Use tooluniverse-systems-biology

---

Input Parameters

ParameterRequiredDescriptionExample
diseaseYesDisease name, OMIM ID, EFO ID, or MONDO IDAlzheimer disease, MONDO_0004975
tissueNoTissue/organ of interestbrain, liver, blood
focus_layersNoSpecific omics layers to emphasizegenomics, transcriptomics, pathways

---

Pipeline Overview

The pipeline runs 9 phases sequentially. Each phase uses specific tools documented in detail in tool-reference.md.

Phase 0: Disease Disambiguation (ALWAYS FIRST)

Resolve disease to standard identifiers (MONDO/EFO) for all downstream queries.

  • Primary tool: OpenTargets_get_disease_id_description_by_name
  • Get description, synonyms, therapeutic areas, disease hierarchy, cross-references
  • CRITICAL: Disease IDs use underscore format (e.g., MONDO_0004975), NOT colon
  • If ambiguous, present top 3-5 options and ask user to select

Phase 1: Genomics Layer

Identify genetic variants, GWAS associations, and genetically implicated genes.

  • Tools: gwas_search_associations (use efo_id for precision, not free-text disease_trait), gwas_get_snps_for_gene, ClinVar, OpenTargets associated targets
  • gnomad_get_gene_constraints — gene constraint metrics (pLI, oe_lof) to interpret whether LoF variants are tolerated vs. haploinsufficient
  • Get top 10-15 genes with genetic evidence scores; track Ensembl IDs for downstream phases

Phase 2: Transcriptomics Layer

Identify differentially expressed genes, tissue-specific expression, and expression-based biomarkers.

  • GTEx_get_expression_summary — baseline expression across 54 tissues (accepts gene_symbol directly)
  • Tools: Expression Atlas, HPA (tissue expression), EuropePMC scores
  • Check expression in disease-relevant tissues for top genes from Phase 1

Phase 3: Proteomics & Interaction Layer

Map protein-protein interactions, identify hub genes, and characterize interaction networks.

  • UniProt_get_function_by_accession — protein function narrative (essential for mechanistic context)
  • Tools: STRING_get_network (param: identifiers, species=9606), intact_get_interactions, HumanBase
  • Build PPI network from top 15-20 genes; identify hub genes by degree centrality

Phase 4: Pathway & Network Layer

Identify enriched biological pathways and cross-pathway connections.

  • ReactomeAnalysis_pathway_enrichment — identifiers are newline-separated (\n), NOT space-separated
  • enrichr_gene_enrichment_analysis — param: gene_list (array), libs (array). NOTE: data field is a JSON string that needs parsing
  • kegg_search_pathway — pathway keyword search

Phase 5: Gene Ontology & Functional Annotation

Characterize biological processes, molecular functions, and cellular components.

  • Tools: Enrichr (GO libraries), QuickGO, GO annotations, OpenTargets GO
  • Run GO enrichment for all 3 aspects (BP, MF, CC)

Phase 6: Therapeutic Landscape

Map approved drugs, druggable targets, repurposing opportunities, and clinical trials.

  • DGIdb_get_drug_gene_interactions — drug interactions by gene (param: genes as array). Often more comprehensive than OpenTargets for drug-gene data.
  • OpenTargets drugs/tractability (use EFO IDs like EFO_0000384 for Crohn's, not MONDO — MONDO IDs may return null for drug queries)
  • search_clinical_trialsquery_term is REQUIRED

Phase 7: Multi-Omics Integration

Integrate findings across all layers. See integration-scoring.md for full details.

  • Cross-layer gene concordance: count layers per gene, score multi-layer hub genes
  • Direction concordance: genetics + expression agreement
  • Biomarker identification: diagnostic, prognostic, predictive
  • Mechanistic hypothesis generation

Phase 8: Report Finalization

Write executive summary, calculate confidence score, verify completeness.

  • See integration-scoring.md for quality checklist and scoring formula

---

Key Tool Parameter Notes

These are the most common parameter pitfalls:

  • OpenTargets disease IDs: underscore format (MONDO_0004975), NOT colon
  • STRING protein_ids: must be array (['APOE']), not string
  • enrichr libs: must be array (['KEGG_2021_Human'])
  • HPA_get_rna_expression_by_source: ALL 3 params required (gene_name, source_type, source_name)
  • humanbase_ppi_analysis: ALL params required (gene_list, tissue, max_node, interaction, string_mode)
  • expression_atlas_disease_target_score: pageSize is REQUIRED
  • search_clinical_trials: query_term is REQUIRED even if condition is provided

For full tool parameters and per-phase workflows, see tool-reference.md.

---

Reference Files

All detailed content is in reference files in this directory:

FileContents
tool-reference.mdFull tool parameters, inputs/outputs, per-phase workflows, quick reference table
report-template.mdComplete report markdown template with all sections and checklists
integration-scoring.mdConfidence score formula (0-100), evidence grading (T1-T4), integration procedures, quality checklist
response-formats.mdVerified JSON response structures for key tools
use-patterns.mdCommon use patterns, edge case handling, fallback strategies

Related skills

How it compares

Choose tooluniverse-multiomic-disease-characterization for full cross-omics disease reports; use tooluniverse-disease-research for lighter disease overviews or GWAS-specific skills when genetics alone is sufficient.

FAQ

How many phases does tooluniverse-multiomic-disease-characterization run?

tooluniverse-multiomic-disease-characterization executes nine phases from disease disambiguation through genomics, transcriptomics, proteomics/PPI, pathways, GO annotation, therapeutics, cross-layer integration, and report finalization with a 0–100 confidence score.

What confidence scoring does tooluniverse-multiomic-disease-characterization use?

tooluniverse-multiomic-disease-characterization grades evidence T1 (human/clinical) through T4 (computational) and calculates a Multi-Omics Confidence Score from 0–100 using the rubric in integration-scoring.md across integrated molecular layers.

Which expression data does tooluniverse-multiomic-disease-characterization query?

tooluniverse-multiomic-disease-characterization uses GTEx_get_expression_summary for baseline expression across 54 tissues plus Expression Atlas and Human Protein Atlas tools to check disease-relevant tissue expression for top genetic candidates.

Data Science & MLanalyticspipelinesetl

This week in AI coding

Five minutes, every Monday - the tools, releases and tactics for developers.

unsubscribe anytime.